Get Involved

Patients and Families

If you or a loved one is struggling with anorexia nervosa, we understand the urgent need for better treatments. While our therapy is still in development, we're committed to keeping patients and families informed about our progress.

Resources for Support

While you wait for new treatments to become available, these organizations provide valuable support and information:

• National Eating Disorders Association (NEDA): www.nationaleatingdisorders.org

• Alliance for Eating Disorders Awareness: www.allianceforeatingdisorders.com

• F.E.A.S.T. (Families Empowered and Supporting Treatment of Eating Disorders): www.feast-ed.org

Sign up below to stay connect and receive updates on our development progress and clinical trials.

Healthcare Professionals

We value collaboration with clinicians and researchers in the eating disorders field. If you're interested in learning more about our approach or potentially participating in future clinical trials, please contact us.

Investors

Zula Therapeutics represents a unique opportunity to deliver both significant social impact and commercial returns. We're seeking impact investors who share our commitment to transforming anorexia nervosa treatment while ensuring broad patient access.

Philanthropy

Through Mount Sinai's Center of Excellence in Eating and Weight Disorders, charitable donations directly support the clinical trials necessary to advance metreleptin therapy for anorexia nervosa. Your tax-deductible contribution helps fund critical research that could lead to the first FDA-approved medication for this deadly condition.

Learn more about Mount Sinai's Research Initiative